- 賽升藥業
- 8.660-0.230 (-2.587%)
盈利能力分析
- 0.138
- 0.433
- -2.027
- 3.023
- 6.187
- 0.131
- 0.409
- -1.920
- 2.862
- 5.874
- 0.134
- 0.421
- -1.970
- 2.936
- 6.064
邊際利潤分析
- 68.106
- 65.115
- 66.282
- 70.426
- 76.638
- 4.090
- 3.068
- -19.923
- 25.544
- 34.666
- 4.944
- 2.829
- -20.470
- 25.414
- 34.602
- 4.219
- 1.925
- -18.458
- 20.230
- 27.588
收益指標分析
- 196.871
- -96.322
- -30.401
- -33.626
- 9.430
- -137.270
- 301.910
- 129.395
- 131.033
- 83.309
- 16.731
- -0.914
- 0.709
- 0.349
- -0.008
償債能力分析
- 20.089
- 18.284
- 20.860
- 26.300
- 17.621
- 19.268
- 17.538
- 19.868
- 24.219
- 16.432
- 4.764
- 4.931
- 4.687
- 4.268
- 4.402
- 0.753
- 0.687
- 0.108
- 0.172
- 0.253
- 12,856.403
- 14,110.891
- 90,494.815
- 56,495.613
- 38,469.304
- 1,986.892
- 1,915.832
- 2,016.513
- 2,222.370
- 2,147.677
- 154.837
- -13.433
- 50.480
- -115.483
- -563.178
營運能力分析
- 40.465
- 39.903
- 40.744
- 46.431
- 40.964
- 219.059
- 191.516
- 241.526
- 250.518
- 222.522
大國博弈
中東戰火
More